Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (1 trial)
dacarbazine (dtic-dome) (1 trial)
enalapril (vasotec) (1 trial)
propranolol (inderal) (1 trial)
Melanoma (Phase 2)
Trials (1 total)
Trial APIs (4 total)